Myeloid Leukemia Clinical Trial
Official title:
Implantation of an Advanced Practice Nurse in the Complex Care Pathway of Patients Followed for AML Treated With Oral Targeted Therapy
Advanced Practice Nurse (APN) is a new contributor in the French healthcare system. APN is part of a multidisciplinary team and aim to monitor patients under the coordination of the doctor particularly in onco-hematology. The aim of the study is to describe the different perceptions and expectations of APN monitoring according to patients with acute myeloid leukemia (AML) and their care team. This study will involve 10 patients, recruited over a provisional period of 5 months and 25 member of care team. Patients and their care team will be asked about their perceptions and expectations of APN participation in (AML monitoring) during a semi-structured interviews.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00001637 -
Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults
|
Phase 2 | |
| Terminated |
NCT00543972 -
Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia
|
Phase 1 | |
| Completed |
NCT00521664 -
A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups
|
Phase 3 | |
| Completed |
NCT05363488 -
Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland
|
||
| Completed |
NCT01380756 -
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
|
Phase 1 | |
| Recruiting |
NCT05031897 -
Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients Who Undergo a Hematopoietic Stem Cell Transplant
|
Phase 2 | |
| Terminated |
NCT00126893 -
Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia
|
Phase 1 | |
| Completed |
NCT03613727 -
Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients
|
Phase 2 | |
| Active, not recruiting |
NCT04714372 -
FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
|
Phase 1 | |
| Completed |
NCT02763475 -
NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents
|
Phase 2 | |
| Terminated |
NCT01643603 -
Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies
|
Phase 1 | |
| Completed |
NCT00497991 -
Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia
|
Phase 1 | |
| Not yet recruiting |
NCT05787951 -
Frequency and Risk Factors of Acute Myeloid Leukemia
|
||
| Completed |
NCT04628338 -
IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
|
Early Phase 1 | |
| Completed |
NCT02719821 -
Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation
|
N/A | |
| Active, not recruiting |
NCT00111345 -
Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents
|
Phase 2/Phase 3 | |
| Completed |
NCT00114764 -
Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)
|
Phase 2 | |
| Recruiting |
NCT05871008 -
Integrated Actionable Aging Assessment for Cancer Patients Pilot
|
N/A | |
| Recruiting |
NCT03638206 -
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05035706 -
Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors
|
Early Phase 1 |